
Sagility Acquires CareSeed to Accelerate AI-Led Quality Operations in Healthcare
Sagility, a leader in technology and AI-led healthcare operations and transformation, has acquired CareSeed, a U.S.-based healthcare analytics company specializing in quality reporting for health plans. This acquisition marks a strategic expansion of Sagility’s capabilities within healthcare quality management and Stars performance enhancement.CareSeed, established in 2012 and based in Kansas City, Missouri, specializes in NCQA-certified HEDIS quality reporting, medical record review, chart abstraction, and regulatory analytics for health plans. The company serves a base of 30 small and mid-sized U.S. payers, holding a strong presence within the Medicare Advantage market.
The acquisition is designed to move Sagility clients beyond retrospective HEDIS reporting toward integrated, member-level quality orchestration. By integrating CareSeed’s specialized technology with Sagility’s existing operational expertise, clinical services, and AI-led transformation capabilities, the combined entity aims to deliver a complete end-to-end quality operations continuum. This offering covers the full quality lifecycle, from HEDIS abstraction and reporting through prospective gap closure, provider engagement, care coordination, and continuous performance monitoring.
Ramesh Gopalan, Managing Director and Group Chief Executive Officer of Sagility, stated that CareSeed has developed strong capabilities in quality measurement, HEDIS reporting, and healthcare analytics necessary for navigating the complex regulatory environment. He added that combining CareSeed’s technology platforms with Sagility's clinical, operational, and AI-enabled transformation services establishes a more connected quality operations model, helping health plans improve member outcomes and enhance Star Ratings performance.
Thomas Mueller, CEO of CareSeed, highlighted that joining Sagility allows the company to leverage its specialized quality analytics and HEDIS capabilities against Sagility’s operational scale and clinical expertise. He noted that clients are under significant pressure to optimize Stars performance and manage growing regulatory complexity, which the merger is positioned to address.
The transaction involves a 100% acquisition of CareSeed and is expected to close on June 11, 2026. The acquisition strengthens Sagility’s market position in the mid-market payer segment while increasing opportunities for scalable quality solutions across larger national health plans.
Key operational data regarding CareSeed are detailed below:
| Metric | Value |
|---|---|
| Founded | 2012 |
| Client Base | 30 small and mid-sized U.S. payers |
| Revenue (CY25) | $5.1 M |
| EBITDA Margin | 31.4% |
CareSeed’s core platforms include Forecast, which provides NCQA-certified HEDIS reporting and quality analytics, and Harvest, which delivers cloud-based medical record review, chart abstraction, and supplemental data capture capabilities.
SAGILITY Stock Price Movement
SAGILITY LIMITED shares shed 1.87% today, finishing in the post-market session at ₹39.26. The stock traded a total volume of 7.78 million shares during the day.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.